Zydus Wellness Ltd.
ZYDUSWELL · NSE · Consumer Defensive
With a 20% margin of safety, our buy-below price is ₹512.74.
Piotroski F-score 5/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%3.4%
- ✕Low debt (D/E < 0.5)0.55x
- ✕Positive free cash flow
- ✓Revenue growth > 10%63%
- ✕Earnings growing-6%
- ✕Net margin ≥ 10%5.0%
- ✓Current ratio > 1.51.88
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✓Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✕Altman Z in safe zoneZ 2.86
- ✕Piotroski ≥ 75/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Weaknesses
- •Low return on equity (3.4%).
Opportunities
- •Revenue growing (63% YoY).
- •Trades ~28% below our estimated fair value.
Threats
- •Earnings contracting year on year.
About Zydus Wellness Ltd.
Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in India, the Middle East, Asia, Africa, the Oceania, and internationally. It provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drink under the Complan brand; glucose-based beverage under the Glucon-D brand; and I'm lite a blended sugar coated with stevia. The company also
More in Fast Moving Consumer Goods
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.